Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...
Hlavní autoři: | Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2020-12-01
|
Edice: | Vaccines |
Témata: | |
On-line přístup: | https://www.mdpi.com/2076-393X/9/1/3 |
Podobné jednotky
-
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
Autor: Robin John Shattock, a další
Vydáno: (2023-11-01) -
Vaccines’ New Era-RNA Vaccine
Autor: Wenshuo Zhou, a další
Vydáno: (2023-08-01) -
Advancing mRNA technologies for therapies and vaccines: An African context
Autor: Dylan Kairuz, a další
Vydáno: (2022-10-01) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
Autor: Bruna Aparecida Souza Machado, a další
Vydáno: (2021-11-01) -
Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
Autor: Janne Snoeck, a další
Vydáno: (2023-11-01)